Skip to main content
CDC Website

TB

Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)

This application, created by the WMA and the New Jersey Medical School Global Tuberculosis Institute, gives physicians the flexibility to access the course material at any time, even when they are discussing treatment options with their patients. The application was developed in collaboration with the World Health Organization with financial support from the Eli Lilly MDR-TB partnership. The application contains the eight training modules which comprise the WMA's course on MDR-TB.

USAID Report on TB: Leading and Leveraging

The US Agency for International Development (USAID) has reported to Congress on its international foreign assistance efforts to control tuberculosis (TB). Titled Leading and Leveraging, the report documents work completed the previous fiscal year.

An Activist’s Guide to Bedaquiline (Sirturo)

This guide is designed to explain the safety and efficacy of bedaquiline. It also describes what you as an activist can do to help ensure access, fair pricing and further research. The guide provides messages that regulatory authorities need to hear to prepare for bedaquiline and other new TB drugs.

Was this page helpful? Give Feedback